Investing in a healthier, humane, and more sustainable future
Portfolio,
Emulate Signs Collaborative Agreement with the FDA to Apply Lung-Chip to Evaluate Safety of COVID-19 Vaccines and Protective Immunity Against SARS-CoV-2
Emulate Signs Collaborative Agreement with the FDA to Apply Lung-Chip to Evaluate Safety of COVID-19 Vaccines and Protective Immunity Against SARS-CoV-2
Emulate, a SDC portfolio company, announced an agreement with the U.S. Food and Drug Administration to enable studies in priority research areas, including programs to evaluate COVID-19 vaccines.
